SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CYBR CyberCare the new look of healthcare -- Ignore unavailable to you. Want to Upgrade?


To: Murray_Mac who wrote (1477)5/2/2000 5:36:00 PM
From: Murray_Mac  Read Replies (1) | Respond to of 3392
 
Justifying my contention that

CYBR share price is currently highly undervalued

in my DD must see link -- ragingbull.com

This guy Mozerd is on a roll and knows what he is talking about.......

Based on the fact that CYBR has on the books, right now, firm commitments for 100,000+ EHC units that will be deployed over a span of the next 4 years. Its quite apparent that few have recognized the earnings impact 100K EHC units will make.

Consider that CYBR has 5 streams of reveneue as follows;

(a) Fee income from Network usage on direct EHC deployment
(b) Net earnings from the sale of EHC?s
(c) Fees income that will accrue from licensing Cyber-Care EHC Patents
(d) Net income that will accrue from joint venture agreements
(e) Fees income from 3rd party participants wishing to join the CYBR Medical Network, and who?s income stream to CYBR could be very huge.

For (a) the Fee net earnings amount to $200/month recurring or $2,400 annually for each EHC unit.
For (b) the net earnings for each EHC sold/deployed is $2,250

Number of shares = 68 million (fully diluted)
Projected net Earnings at full deployment = $465 million [includes (a) and (b)]
Projected Earnings per share (EPS) = $6.84 (Net Earnings divided by number of shares)
Price to Earnings per share (PE/s) = $137.00 (EPS times a conservative multiple of 20)
- May 1, 2000 CYBR closing-price = $15 1/8

Now ponder the fact that my EPS calculations above do not take into account any (c) Fee income that will accrue from licensing Cyber-Care EHC Patents or (d) Net income that will accrue from joint venture agreements or (e) Fee income from 3rd party participants wishing to join the CYBR Medical Network, and who?s income stream to CYBR could be very huge.

If you?re wondering why I have not included these other earnings streams ? because CYBR have not as yet divulged all pertinent information for (c) - (d) - (e) and adds to the conservative nature of this PE projection.

Now consider the potential PE -- based of the following table that provides an outline based on EHC deployment numbers in excess of 100,000 units.

Number
of EHC Total Gross Income Total Net Income EPS PE
100,000 $836,000,000 $465,000,000 $6.84 $137
200,000 $1,672,000,000 $930,000,000 $13.68 $274
300,000 $2,508,000,000 $1,395,000,000 $20.51 $410
400,000 $3,344,000,000 $1,860,000,000 $27.35 $547
500,000 $4,180,000,000 $2,325,000,000 $34.19 $684
600,000 $5,016,000,000 $2,790,000,000 $41.03 $821
700,000 $5,852,000,000 $3,255,000,000 $47.87 $957
800,000 $6,688,000,000 $3,720,000,000 $54.71 $1,094
900,000 $7,524,000,000 $4,185,000,000 $61.54 $1,231
1,000,000 $8,360,000,000 $4,650,000,000 $68.38 $1,368
1,100,000 $9,196,000,000 $5,115,000,000 $75.22 $1,504

**********************************************************************************************************************

..DM..

(Voluntary Disclosure: Position- Long; ST Rating- Strong Buy; LT Rating- Strong Buy)